Matthew T. Chang 1 , 2 , 3 , Saurabh Asthana 4 , Sizhi Paul Gao 1 , Byron H. Lee 5 , Jocelyn S. Chapman 6 , Cyriac Kandoth 7 , JianJiong Gao 7 , Nicholas D. Socci 7 , 8 , David B. Solit 1 , 7 , 9 , 10 , Adam B. Olshen 11 , 12 , Nikolaus Schultz 2 , 7 , Barry S. Taylor 1 , 2 , 7
30 November 2015
Mutational hotspots indicate selective pressure across a population of tumor samples, but their prevalence within and across cancer types is incompletely characterized. An approach to detect significantly mutated residues, rather than methods that identify recurrently mutated genes, may uncover new biologically and therapeutically relevant driver mutations. Here we developed a statistical algorithm to identify recurrently mutated residues in tumour samples. We applied the algorithm to 11,119 human tumors, spanning 41 cancer types, and identified 470 hotspot somatic substitutions in 275 genes. We find that half of all human tumors possess one or more mutational hotspots with widespread lineage-, position-, and mutant allele-specific differences, many of which are likely functional. In total, 243 hotspots were novel and appeared to affect a broad spectrum of molecular function, including hotspots at paralogous residues of Ras-related small GTPases RAC1 and RRAS2. Redefining hotspots at mutant amino acid resolution will help elucidate the allele-specific differences in their function and could have important therapeutic implications.